Aminosalicylic acid delayed-release granules - Jacobus Pharmaceutical/Lucane Pharma

Drug Profile

Aminosalicylic acid delayed-release granules - Jacobus Pharmaceutical/Lucane Pharma

Alternative Names: 4-Aminosalicylic acid - Lucane Pharma SA; Aminosalicylic acid delayed release granules - Jacobus Pharmaceutical/Lucane Pharma; GranuPAS; Para-aminosalicylic acid (PAS) - Lucane Pharma SA; Para-aminosalicylic acid gastro-resistant granules; PAS-GR; Paser; Paser granules - Jacobus Pharmaceutical/Lucane Pharma

Latest Information Update: 26 Feb 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Jacobus Pharmaceutical
  • Developer Jacobus Pharmaceutical; Lucane Pharma; Medical Need
  • Class Anti-inflammatories; Antituberculars; Salicylates
  • Mechanism of Action Dihydropteroate synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Tuberculosis
  • New Molecular Entity No

Highest Development Phases

  • Marketed Tuberculosis

Most Recent Events

  • 15 Dec 2016 Biomarkers information updated
  • 24 Feb 2015 Aminosalicylic acid delayed-release granules - Jacobus Pharmaceutical/Lucane Pharma receives Orphan Drug status for Tuberculosis (Combination therapy) in Australia
  • 30 Mar 2012 Preregistration for multidrug resistant Tuberculosis in European Union (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top